Viewing Study NCT03217266


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2026-02-18 @ 2:48 PM
Study NCT ID: NCT03217266
Status: COMPLETED
Last Update Posted: 2025-09-23
First Post: 2017-07-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2017-01234
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View